Lineage Cell Therapeutics, Inc. (LCTX)

Every official Lineage Cell Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports, proxy statements, shareholding and announcements, straight from the regulator. Free to search.

Lineage Cell Therapeutics, Inc. documents

• Lineage Cell Therapeutics, Inc. 10-K 2026LCTX 10-K 2026: annual report for fiscal 2026
• Lineage Cell Therapeutics, Inc. 10-K 2025LCTX 10-K 2025: annual report for fiscal 2025
• Lineage Cell Therapeutics, Inc. 10-K 2024LCTX 10-K 2024: annual report for fiscal 2024
• Lineage Cell Therapeutics, Inc. 10-K 2023LCTX 10-K 2023: annual report for fiscal 2023
• Lineage Cell Therapeutics, Inc. 10-K 2022LCTX 10-K 2022: annual report for fiscal 2022
• Lineage Cell Therapeutics, Inc. 10-Q 2026LCTX 10-Q 2026: quarterly report for fiscal 2026
• Lineage Cell Therapeutics, Inc. 10-Q 2025LCTX 10-Q 2025: quarterly report for fiscal 2025
• Lineage Cell Therapeutics, Inc. 10-Q 2024LCTX 10-Q 2024: quarterly report for fiscal 2024
• Lineage Cell Therapeutics, Inc. 10-Q 2023LCTX 10-Q 2023: quarterly report for fiscal 2023
• Lineage Cell Therapeutics, Inc. 10-Q 2022LCTX 10-Q 2022: quarterly report for fiscal 2022
• Lineage Cell Therapeutics, Inc. 8-K 2026LCTX 8-K 2026: current report for fiscal 2026
• Lineage Cell Therapeutics, Inc. 8-K 2025LCTX 8-K 2025: current report for fiscal 2025
• Lineage Cell Therapeutics, Inc. 8-K 2024LCTX 8-K 2024: current report for fiscal 2024
• Lineage Cell Therapeutics, Inc. 8-K 2023LCTX 8-K 2023: current report for fiscal 2023
• Lineage Cell Therapeutics, Inc. 8-K 2022LCTX 8-K 2022: current report for fiscal 2022
• Lineage Cell Therapeutics, Inc. DEF 14A 2026LCTX DEF 14A 2026: proxy statement for fiscal 2026
• Lineage Cell Therapeutics, Inc. DEF 14A 2025LCTX DEF 14A 2025: proxy statement for fiscal 2025
• Lineage Cell Therapeutics, Inc. DEF 14A 2024LCTX DEF 14A 2024: proxy statement for fiscal 2024
• Lineage Cell Therapeutics, Inc. DEF 14A 2023LCTX DEF 14A 2023: proxy statement for fiscal 2023
• Lineage Cell Therapeutics, Inc. DEF 14A 2022LCTX DEF 14A 2022: proxy statement for fiscal 2022
• Lineage Cell Therapeutics, Inc. Form 4 2026LCTX Form 4 2026: insider trading filing for fiscal 2026
• Lineage Cell Therapeutics, Inc. Form 4 2025LCTX Form 4 2025: insider trading filing for fiscal 2025
• Lineage Cell Therapeutics, Inc. Form 4 2024LCTX Form 4 2024: insider trading filing for fiscal 2024
• Lineage Cell Therapeutics, Inc. Form 4 2023LCTX Form 4 2023: insider trading filing for fiscal 2023
• Lineage Cell Therapeutics, Inc. Form 4 2022LCTX Form 4 2022: insider trading filing for fiscal 2022
• Lineage Cell Therapeutics, Inc. S-1 2026LCTX S-1 2026: registration statement for fiscal 2026
• Lineage Cell Therapeutics, Inc. S-1 2025LCTX S-1 2025: registration statement for fiscal 2025
• Lineage Cell Therapeutics, Inc. S-1 2024LCTX S-1 2024: registration statement for fiscal 2024
• Lineage Cell Therapeutics, Inc. S-1 2023LCTX S-1 2023: registration statement for fiscal 2023
• Lineage Cell Therapeutics, Inc. S-1 2022LCTX S-1 2022: registration statement for fiscal 2022
• Lineage Cell Therapeutics, Inc. 13F 2026LCTX 13F 2026: institutional holdings for fiscal 2026
• Lineage Cell Therapeutics, Inc. 13F 2025LCTX 13F 2025: institutional holdings for fiscal 2025
• Lineage Cell Therapeutics, Inc. 13F 2024LCTX 13F 2024: institutional holdings for fiscal 2024
• Lineage Cell Therapeutics, Inc. 13F 2023LCTX 13F 2023: institutional holdings for fiscal 2023
• Lineage Cell Therapeutics, Inc. 13F 2022LCTX 13F 2022: institutional holdings for fiscal 2022

More companies